Can ultrasound of the major salivary glands assess histopathological changes induced by treatment with rituximab in primary Sjögren's syndrome?

Ann Rheum Dis. 2019 Apr;78(4):e27. doi: 10.1136/annrheumdis-2018-213332. Epub 2018 Mar 9.

Affiliations

¹ Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, The Netherlands.
² Department of Oral and Maxillofacial Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
³ Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

PMID: 29523521
DOI: 10.1136/annrheumdis-2018-213332

No abstract available

Keywords: sjøgren’s syndrome; treatment; ultrasonography.

Publication types

Letter
Comment

MeSH terms

Double-Blind Method
Humans
Rituximab
Salivary Glands
Sjogren's Syndrome*
Ultrasonography

Substances

Rituximab